Source: RQM+ Blog

RQM+ Blog Braving the Tariff Storm: Strategies for MedTech Companies

The U.S. administration has announced plans to implement a 25% tariff on imported medical technologies (MedTech), pharmaceuticals, and automobiles, set to take effect today, April 2, 2025. This significant policy shift will undoubtedly impact the MedTech industry, requiring companies to adapt their strategies to mitigate the financial burden. Considering recent political instability, it's crucial to reassess and optimize your supply chain and manufacturing processes.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
John Potthoff's photo - CEO of RQM+

CEO

John Potthoff

CEO Approval Rating

82/100

Read more